The importance of group A hemolytic streptococcal infections in the pathogenesis of rheumatic fever is widely recognized, but little is known of the mechanism by which the streptococcal infection gives rise to the disease. The concept that an antigen-antibody interaction may be involved in the origin of the pathologic processes has received increasing attention, and recent antibody studies (1, 2) provide suggestive evidence in support of this point of view. For example, studies in several laboratories dealing with a variety of streptococcal antigens have demonstrated that the mean antibody response of a group of rheumatic fever patients to these antigens is greater than that of a comparable group of patients with uncomplicated streptococcal disease (3) (4) (5) (6) . In view of these findings, it is of importance to determine whether the hyperreactivity of rheumatic subjects is limited to antigens derived from the streptococcus or is a reflection of a fundamental difference which would be demonstrable in an enhanced response to a variety of different antigens.
Because it has been impossible in natural infections with the hemolytic streptococcus to obtain accurate quantitative information concerning the antigenic stimulus, one of the possible explanations of the relative enhancement of the immune response in rheumatic subjects is that these individuals may have been exposed to comparatively greater quantities of antigen. At the present time it is difficult to approach this problem experimentally using streptococcal antigens, but other antigens are available, some in highly purified 1 Established Investigator of the American Heart Association. The form, for use in a comparative study of the antibody response in rheumatic and control subjects. By this approach it should be possible to determine whether the exaggerated response to an antigenic stimulus is a general characteristic of rheumatic subjects. However, a negative result would not invalidate the hypothesis that rheumatic fever is related to hypersensitivity to the hemolytic streptococcus or its products. On the other hand, a discrepancy in the responses of rheumatic and control individuals would support the thesis that rheumatic subjects possess an innate difference in the antibody forming mechanism.
In the present study, diphtheria toxoid was selected as the immunizing antigen because it was considered to possess a number of advantages over other possible materials. It is available as a highly purified substance, and sensitive procedures have been devised for the measurement of antitoxin. Furthermore, quantitative studies have shown that highly purified diphtheria toxoid and human antitoxin behave as a single antigen-antibody system. In addition, the use of this system makes it possible to obtain qualitative as well as quantitative data concerning antibody formation, since techniques are available to study both precipitating and nonprecipitating antitoxin (7) (8) (9) .
The investigations to be reported are based upon skin reactions observed in 245 Schick tested rheumatic and control subjects and upon the antitoxin responses occurring in 121 of these individuals following a single booster dose of purified diphtheria toxoid.
MATERIALS AND METHODS
Clinical material. The total study group consisted of 245 individuals; 132 members gave a history of rheumatic fever or rheumatic heart disease and this group was comprised of (a) 104 'Schick toxin and control were diluted in Glenny's borate buffer containing 0.4 per cent of heated human serum albumin and 0.02 per cent merthiolate (10) .
gether with other tests to be described, as an indication of possible differences in antibody reactivity. Immediate reactions were read at the Schick control site 15 to 30 minutes after performing the Schick test. The diameter of the area of wheal and of erythema were both measured and the presence of pseudopodia, pruritis, and color intensity noted. On the basis of these criteria, reactions were rated as negative, ±, +, ++, +++, ++++ (8) . In the adult groups additional skin sites were injected with 0.1 cc. buffered human albumin (Schick diluent) as a control and equally strong immediate reactions against both toxoid and albumin diluent were arbitrarily classified as negative. The Schick test was read at 48 hours.
Immunization. Immunization was carried out in 121 individuals who were Schick negative and who did not show a delayed reaction to Schick control toxoid at 48 hours. After the Schick test was read, a single injection of purified diphtheria toxoid was given subcutaneously. The dose was 37.5 Lf fluid toxoid or 200 Lf of purified toxoid absorbed on alumina cream6 (11) . Forty-four adult male Schick negative rheumatic subjects and an equal number of non-rheumatic male controls received 37.5 Lf fluid toxoid (1 cc.) . Twenty-two Schick negative rheumatic children (17 male and 5 female) and 11 male controls received 200 Lf alum toxoid (1 cc.). Local reactions subsequent to immunization were mild or nonexistent except in three instances where a febrile response was accompanied by considerable local swelling and discomfort.
Pre-immunization bleedings were taken at the time the Schick tests were given. Following the booster dose of toxoid given 48 hours later, post-immunization bleedings were drawn between the first and second, and second and third weeks, usually the ninth and nineteenth days, and in certain cases at intervals thereafter. Serum was removed using sterile precautions and stored in small glass tubes at 4°C. until used.
Antibody determinations. The in vivo antitoxin titer was determined using the rabbit intracutaneous test, following the technic of Fraser (12) . Unknown specimens were compared with a simultaneous titration carried out with standard antitoxin obtained from the National Institutes of Health. Dilutions were spaced in such a manner that the titrations were accurate to within 15 to 20 per cent.
Tests for specific precipitation of antitoxin with toxin were carried out by a capillary tube precipitation method (13) . A single concentration of serum containing an appropriate amount of antitoxin was mixed with varying amounts of toxin. On the basis of titers obtained using the rabbit skin test, sera of sufficiently high titer were diluted to contain about 30 units per cc. Other specimens containing between 10 and 30 units per cc. were used undiluted. The amount of toxin varied from 5 Lf to 40 Lf per cc. The purified toxin used contained 2480 Lf per cc. and 1 Lf was equivalent to 0.46 jg. specifically pre-cipitable Nitrogen.7 The approximate point of equivalence was taken as the tube in which maximal precipitation resulted following two hours of incubation at 37°C. and overnight incubation at 4°C. Quantitative precipitin titers were performed in the case of some sera by methods described elsewhere (7) and in vivo/in zitro ratios were determined in these instances. This ratio indicates the proportion of total antitoxin that is precipitable and thus provides an index of the amount of non-precipitating antibody.
Criteria used to determine the presence of human nonprecipitating antitoxin have been described in detail in another publication (9) : the criteria used in this study included immediate skin reactivity to Schick toxoid, the relative ability of antitoxin containing sera to form specific precipitates in the presence of purified toxin or toxoid, and the ability to fix guinea pig complement. Individuals showing immediate skin reactivity to Schick toxoid possess non-precipitating, skin sensitizing diphtheria antitoxin. Sera containing this type of antitoxin demonstrate poor or no fixation of guinea pig complement in contrast to precipitating antitoxin which is usually able to fix relatively large amounts of complement. The technique employed in comparing the complement fixing ability of various antitoxin-containing sera has been described elsewhere (9) . Evaluation of rheumatic and control sera in regard to the presence of non-precipitating antitoxin was made on the basis of whether more or less than one unit of antitoxin in sera containing 10 units or more per cc. was capable of binding two units of guinea pig complement. Past experience has shown this to be a convenient level of demarcation in judging relative amounts of precipitating and non-precipitating antitoxin in a given serum.
Because it was thought of interest to determine the possible non-specific anamnestic rise of antibodies to a product of the streptococcus following administration of diphtheria toxoid, antistreptolysin 0 determinations were performed on pre-and post-immunization sera of the young-age-group rheumatic and control subjects who received alum toxoid. The method used was that described by Todd as modified by Hodge and Swift (14) .
RESULTS
Reactions to the Schick test Table Ia (Table IV) was the same as that of the adult series at nine days, but was considerably less than the mean adult response at nineteen days. As in the adult group, a wide range in titer responses was demonstrated. Greater quantities of antitoxin were formed in the young control subjects. This is a factor of doubtful significance because the small group (11 subjects) included two persons who formed particularly large amounts of antitoxin. If these two members are eliminated from the series, mean titers are obtained which approximate those of the rheumatic patients.
There seems to be no apparent difference in the post-immunization antitoxin response between subjects giving a history of a single attack of rheumatic fever and patients with a history of more than one attack. Comparison was made between maximum titers observed in 49 rheumatic children or adults who gave a history of but one attack of rheumatic fever, and in 17 subjects who gave a history of more than one rheumatic fever attack. The range of titer in the former group was from 1 to 300 units per cc. with a mean titer of 46 units per cc.; in the latter group the titer also ranged from 1 to 300 units per cc. with a mean titer of 45 units per cc.
The foregoing evidence suggests that the antitoxin response is quantitatively similar in rheumatic and control subjects.
Nature of the antitoxin produced following hyperimmunization with diphtheria toxoid
In order to determine whether rheumatic subjects possessed a superior ability to form nonprecipitating antitoxin compared with the con- There was a marked similarity in reactions demonstrated by sera in both groups (total of 49 subjects tested) as judged by the ability to fix a standard amount of guinea pig complement (see Table V ). Analogous results were also observed when the sera of 50 subjects were tested for the ability to form precipitate when mixed with an approximately equivalent amount of toxin using the qualitative technique (Table VI) . In order to demonstrate possible quantitative differences, quantitative precipitin titers were carried out using sera of sixteen rheumatic patients in the younger age category. All of these sera contained 15 Because of the possibility that an unusual type of antibody may play a role in rheumatic fever, it was thought of importance in the present work to determine whether differences occur between rheumatic and non-rheumatic subjects in the type of diphtheria antitoxin produced. Earlier studies (8) have shown that human subjects immunized with purified diphtheria toxoid form either precipitating antitoxin, non-precipitating antitoxin, or a mixture of both. The present investigations confirm the original studies, and in addition, show no significant numerical differences between rheumatic and control groups in the ability to form one or both varieties of antitoxin as measured by the immediate skin test, specific precipitability, the in vivo/in vitro ratio, and fixation of guinea pig complement. 8 The possibility that rheumatic patients more readily produce a non-precipitating form of antibody, or a group of such antibodies to certain products of the group A hemolytic streptococcus cannot be ruled out on the basis of the studies described, since an unrelated antigen was used. However, a generalized tendency to this kind of immune response in rheumatic individuals is not suggested by our results.
There is some evidence which indicates that so-called anamnestic antibody responses occur following exposure to, or stimulation with, unrelated materials (18) (19) (20) , but there is likewise a considerable body of experimental data (21) (22) (23) to show that anamnestic responses occur only subsequent to stimulation with antigenically related substances. In the present study, the absence of rises in antistreptolysin 0 during the period of maximum diphtheria antitoxin response is in accord with the view that non-specific antibody responses do not occur.
SUMMARY
The present study was based upon analysis of skin reactions to Schick toxin and toxoid in 245 rheumatic and control subjects, and upon antitoxin responses in 121 of these individuals following a single booster dose of purified diphtheria toxoid.
The amounts of antitoxin produced in rheumatic and control subjects subsequent to a booster dose of diphtheria toxoid were similar with regard to the range of titer and the mean titer. The course of antitoxin responses in rheumatic patients studied up to 80 days was similar in most instances to that of control subjects. 8 On the basis of current investigations in this laboratory, it is probable that non-precipitating antitoxin occurs in a form which does not sensitize human skin. This possibility was raised with regard to the original studies (8) because a few sera containing non-precipitating antitoxin possessed relatively high antitoxin titers in the presence of only moderate skin reactivity to toxoid. In the present investigation, several individuals in both rheumatic and control groups who demonstrated no reactivity to Schick toxoid possessed antitoxin which was not precipitable by toxoid. Further related studies using additional immunological techniques are now in progress. The above finding would seem to have no bearing on the present studies, since there was no significant difference in the number of precipitin formers (Table VI) or of immediate skin reactors (Tables I and II) between the rheumatic and control groups.
There was no demonstrable difference in the post-immunization antitoxin response between subjects with a history of one rheumatic fever attack and patients with a history of more than one attack.
Comparison of the relative ability of rheumatic and control subjects to form non-precipitating antitoxin was made on the basis of immediate wheal and erythema reactions to Schick toxoid, specific precipitability with toxoid, analysis of the in vivo/ in vitro ratio and guinea pig complement fixation. The results of these tests in both groups showed no significant differences.
The above data indicate that, qualitatively and quantitatively, antitoxin responses to diphtheria toxoid are approximately the same in rheumatic and non-rheumatic individuals.
Antistreptolysin 0 titers, determined in rheumatic and control children during the period of maximal diphtheria antitoxin formation, showed no consistent rises in either group.
